Research Chem Review 2026: GLP Trifecta, KLOW Blend & Competitive Per-Mg Peptide Pricing

# Research Chem Review 2026: GLP Trifecta, KLOW Blend & Competitive Per-Mg Peptide Pricing

> Disclaimer: All Research Chem products listed on Peptides.SO are sold exclusively for laboratory and in-vitro scientific research. They are not approved for human or veterinary use. This review is provided for informational and research-procurement purposes only.

Research Chem (researchchemhq.co) is a U.S.-based research compound supplier with 32 active listings on Peptides.SO. The company occupies a distinctive niche in the research peptide market: it covers the full GLP receptor agonist spectrum through its proprietary RC-series naming convention, offers the industry-standard KLOW multi-compound healing blend, and delivers some of the lowest verified per-milligram pricing across several compound classes — including Melanotan I at $3.00/mg, Thymosin Beta-4 at $9.00/mg, and Cagrilintide at $5.00/mg.

Company Overview

Research Chem operates as a curated multi-category supplier serving research programs that require coverage across metabolic biology, tissue healing, neuroprotection, and anti-aging compound research. Its catalog architecture reflects an awareness of what contemporary research programs prioritize: the RC-1S/2T/3R naming series for GLP compounds, the KLOW and Beauty blend formats for combination peptide research, and a cosmetic-science segment anchored by GHK-Cu formulations.

The researchchemhq.co domain positions the company in the research chemical supplier category, and the catalog confirms a research-only orientation — no clinical or therapeutic representations are made. Researchers who have compared multiple U.S. suppliers find Research Chem consistently competitive on per-mg pricing, particularly for GLP-1 receptor compounds, amylin research peptides, and cosmetic-science peptides.

Catalog & Products

GLP Receptor Research Series (RC-1S / RC-2T / RC-3R)

Research Chem's defining catalog feature is its proprietary RC-series naming for the three major GLP receptor agonist research compounds:

RC-1S (Semaglutide) is available in two vial sizes, reflecting Research Chem's awareness that GLP-1 receptor agonist research programs vary in scale. Semaglutide is a GLP-1 receptor agonist studied for its effects on glucose-stimulated insulin secretion, gastric motility, adipose tissue lipolysis signaling, and incretin pharmacology. The acylated fatty-acid side chain confers prolonged albumin binding relative to native GLP-1, making it a preferred research tool for studying sustained GLP-1 receptor occupancy. Research using Semaglutide as a reference compound has contributed substantially to incretin biology understanding since the compound entered clinical pharmacology in the 2010s.

RC-2T (Tirzepatide) represents dual GLP-1R/GIPR agonism. Tirzepatide is a 39-amino acid peptide with C20 fatty diacid modification that enables prolonged half-life through albumin binding. Its dual receptor activity produces effects on glucose-stimulated insulin secretion that are distinctly different from GLP-1 monotherapy: GIP receptor co-stimulation promotes additional beta-cell function, differential effects on adipokine secretion (particularly adiponectin), brown adipose tissue thermogenesis, and hepatic lipid metabolism. Tirzepatide research has generated significant literature in the 2023–2026 period, and Research Chem's RC-2T product supports continued study in dual-receptor biology.

RC-3R (Retatrutide) provides access to the frontier triple-receptor agonism research space. Retatrutide (LY3437943) activates GLP-1R, GIPR, and glucagon receptor (GCGR) simultaneously. The addition of glucagon receptor agonism to the dual-incretin base adds a third pharmacological dimension: direct hepatic glycogenolysis stimulation, augmented energy expenditure through UCP-1 upregulation in brown adipose tissue, and enhanced fatty acid oxidation rates distinct from GLP-1-only mechanisms. RC-3R is one of the few research-vendor presentations of this compound available from a U.S. domestic source, making it a valuable catalog addition for researchers studying next-generation incretin pharmacology.

Cagrilintide (10mg at $5.00/mg) extends the metabolic biology catalog into amylin receptor agonism. Cagrilintide is a long-acting amylin analog studied in combination with GLP-1 receptor agonists for synergistic effects on food intake regulation, gastric emptying, and glucagon suppression. Amylin receptors are heteromers of calcitonin receptor with receptor activity-modifying proteins (RAMPs), and Cagrilintide's selective binding profile makes it a research tool for disentangling amylin receptor subtypes in metabolic signaling.

KLOW Blend: Multi-Compound Tissue Healing Research

The KLOW Blend (80mg; BPC-157/TB-500/KPV/GHK-Cu) is a multi-compound formulation available at $74.99 for the 80mg vial. The four components represent distinct but complementary mechanisms in tissue healing biology:

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide studied in gastrointestinal mucosal healing, angiogenesis promotion, tendon repair, and systemic tissue protection via interactions with growth hormone receptor and nitric oxide signaling pathways. BPC-157 research has demonstrated protective effects in gastric fistula, wound healing, bone repair, and organ-protective contexts across multiple rodent and cell-culture models.

TB-500 (Thymosin Beta-4) is a 43-amino acid peptide studied for its actin-sequestering activity, cell motility promotion, wound healing acceleration, and anti-inflammatory signaling. Research has demonstrated TB-500's role in promoting stem cell differentiation, cardiac repair following ischemic injury, and neurological recovery models. Available separately at $89.99 for 10mg ($9.00/mg) — one of the more competitive TB-500 prices among verified U.S. suppliers.

KPV (Lys-Pro-Val), the C-terminal tripeptide of α-melanocyte-stimulating hormone, has been studied for its anti-inflammatory and mucosal healing properties through melanocortin receptor signaling — particularly MC1R. Research suggests KPV may downregulate NF-κB-mediated inflammatory cascades relevant to intestinal barrier function studies.

GHK-Cu (Copper Peptide) is a naturally occurring copper tripeptide studied in wound healing acceleration, collagen and elastin synthesis stimulation, anti-inflammatory signaling, antioxidant enzyme activity, and angiogenesis promotion. Research Chem offers GHK-Cu in two distinct formats: the standard KLOW blend and a 1g ampule topical GHK-Cu formulation ($79.99) designed for cosmetic-science and transdermal delivery research.

Beauty Blend: GHK-Cu / KPV Cosmetic Research Formulation

The Beauty Blend (GHK-Cu/KPV, 50mg/20mg) at $79.99 is a dual-peptide formulation targeting synergistic wound healing and skin biology research. The combination leverages GHK-Cu's collagen stimulation and KPV's anti-inflammatory activity, making it a relevant research tool for studies examining cosmetic peptide interactions at the dermal-epidermal interface.

The GHK-Cu topical 1g ampule ($79.99) provides a high-volume format for researchers with larger-scale cosmetic-science study designs or those requiring a transdermal-compatible carrier format.

Cognitive & Neuroprotective Research Peptides

Research Chem lists both Semax ($59.99) and Selank ($79.99) — two synthetic peptides originally developed in Russian neuroscience research.

Semax is a synthetic heptapeptide analogue of ACTH (4-10) studied for neuroprotective activity, BDNF and NGF upregulation, anti-inflammatory brain effects, and cognitive enhancement models in stroke and oxidative stress paradigms. It acts primarily through BDNF/TrkB signaling pathways and serotonergic and dopaminergic modulation.

Selank is a synthetic heptapeptide analogue of tuftsin (Thr-Lys-Pro-Arg) with modifications conferring enhanced stability and CNS penetration. Research has examined anxiolytic effects without sedation, GABA-A receptor modulation, and stress-response system normalization in animal models. Selank is particularly interesting for researchers studying anxiety biology without benzodiazepine receptor interference.

Metabolic & Anti-Aging Research Stack

Research Chem builds out its metabolic and anti-aging category with:

• •MOTS-c ($89.99): A mitochondria-derived peptide encoded within the 12S rRNA region of mitochondrial DNA. MOTS-c research has demonstrated roles in insulin sensitivity promotion, fatty acid beta-oxidation regulation, and metabolic adaptation to caloric restriction. It activates AMPK signaling and has been studied in the context of type 2 diabetes prevention and exercise-mimetic pharmacology.

• •5-Amino-1MQ ($79.99): A small-molecule nicotinamide N-methyltransferase (NNMT) inhibitor studied for its ability to increase intracellular NAD+ levels by preventing NNMT from consuming methyl groups in a competing pathway. Research has examined its effects on adipocyte differentiation, lipid accumulation, and metabolic rate in cell culture models.

• •SLU-PP-332 capsules (500mcg × 60 at $179.99; also 500mcg tablet format at $89.99): An ERRα/β/γ agonist studied as an exercise mimetic. SLU-PP-332 activates estrogen-related receptors to mimic transcriptional responses to endurance exercise without physical activity — a promising research tool for metabolic disease models where exercise is contraindicated or difficult to standardize.

• •Tesofensine ($179.99): A triple monoamine reuptake inhibitor (norepinephrine, dopamine, serotonin) originally studied for Parkinson's disease pharmacology. Research has since focused on its potent appetite-suppressing and metabolic rate-increasing properties in obesity models, with significantly stronger effect magnitudes than single-mechanism monoamine reuptake inhibitors.

• •NAD+ ($109.99) for nicotinamide coenzyme research in cellular energy metabolism, sirtuin activation, and PARP activity studies.

• •Tesamorelin ($139.99): A 44-amino acid stabilized analogue of GHRH studied for growth hormone secretagogue activity and body composition effects, particularly visceral adipose tissue reduction in HIV-associated lipodystrophy research models.

• •PT-141 (Bremelanotide) ($79.99): An FDA-approved melanocortin receptor agonist (MC3R/MC4R) with research applications in sexual dysfunction models and melanocortin circuit biology. PT-141 activates central melanocortin pathways distinct from peripheral PDE5 inhibitor mechanisms.

Growth Hormone Axis Coverage

The CJC-1295 no DAC (5mg at $109.99 = $22.00/mg) and CJC-1295 no DAC/Ipamorelin dual blend expand the GHRH/GHRP research coverage. While not the most competitive CJC pricing in the market, the availability alongside the GLP series in a single catalog simplifies procurement for multi-axis research programs.

Pricing Analysis

Research Chem's per-mg pricing benchmarks across verified compounds:

The Melanotan I price at $3.00/mg (10mg vial) is among the lowest verified figures for this compound from a U.S.-domestic source. TB-500 at $9.00/mg is competitive relative to suppliers like TruLab ($8-10/mg range) and significantly below vendors pricing at $12-18/mg. Cagrilintide access at competitive per-mg rates distinguishes Research Chem in the amylin research segment.

Quality & Testing Standards

Research Chem follows the third-party analytical testing standard expected of documented U.S. research compound suppliers: HPLC purity characterization and mass spectrometry identity confirmation per production batch, with COA documentation available to purchasing researchers. The COA framework ensures that purity and identity claims are backed by instrument-verified data rather than supplier assertions alone.

Third-party testing matters particularly for GLP-series compounds, where structural complexity (multiple disulfide bonds in some analogs, fatty acid conjugation, complex chirality) creates greater synthesis difficulty and corresponding quality variance risk. Research programs using RC-1S, RC-2T, or RC-3R should confirm COA documentation covers both purity percentage (HPLC area%) and identity confirmation (LC-MS molecular weight verification).

Shipping & Customer Service

Research Chem ships domestically within the United States with standard and expedited options available. Processing times align with the U.S. research supplier standard of one to three business days. Compounds requiring cold-chain handling (lyophilized peptides with standard temperature stability) ship with appropriate insulation for short-transit periods, with recommendations for immediate refrigeration upon receipt.

Customer support handles product inquiries, order status, and COA access requests. Researchers note that the RC-series naming convention simplifies ordering — each proprietary designation maps clearly to its underlying compound — reducing confusion in procurement workflows where generic names overlap with multiple trade presentations.

Pros & Cons

Pros

• •Full GLP receptor agonist coverage (GLP-1 / GLP-1+GIP / GLP-1+GIP+GCGR)
• •Cagrilintide availability for amylin+GLP combination research
• •Among the lowest verified Melanotan I pricing at $3.00/mg
• •TB-500 at $9.00/mg is competitive for a quality-documented U.S. source
• •KLOW Blend (BPC-157/TB-500/KPV/GHK-Cu) available as a single-vial combination
• •Beauty Blend GHK-Cu/KPV for cosmetic peptide interaction research
• •Both Semax and Selank for cognitive/neuroprotective research coverage
• •SLU-PP-332 and Tesofensine for frontier metabolic research
• •GHK-Cu 1g topical ampule for cosmetic-science applications
• •Clear research-only positioning with COA documentation

Cons

• •CJC-1295 no DAC pricing ($22/mg) is higher than the most competitive vendors
• •No GHRP class compounds (GHRP-2, GHRP-6, Hexarelin, Ipamorelin standalone) for dedicated GHRP pharmacology research
• •SARMs not covered (single-category researchers may need a secondary supplier)
• •RC-series naming can require cross-referencing for researchers unfamiliar with the convention

Verdict

Research Chem earns a strong position in the 2026 U.S. research peptide market through a combination of broad GLP receptor agonist coverage, the complete KLOW healing stack, and verified competitive pricing on several anchor compounds. The $3.00/mg Melanotan I and $9.00/mg TB-500 are notable for researchers who order these compounds at volume. The RC-3R (Retatrutide) access makes Research Chem one of the few domestic U.S. sources for triple-receptor GLP biology research.

Researchers working primarily on GLP receptor pharmacology, incretin biology, amylin signaling, tissue healing, or cosmetic-science peptides will find the catalog well-suited to their needs. Those requiring dedicated GHRP or SARM coverage will need a secondary source, but for the metabolic and healing-compound categories Research Chem covers, the combination of price and quality documentation is competitive with the strongest vendors in each category.

---

For research purposes only. Not for human use. All products are sold exclusively for in-vitro laboratory research.

Internal links: BPC-157 • TB-500 • Semaglutide • Tirzepatide • GHK-Cu • Semax • Selank • Compare suppliers